Metropolitan Digital

Men's Weekly


.

The FDA's lax oversight of research in developing countries can do harm to vulnerable participants

  • Written by C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut
The FDA's lax oversight of research in developing countries can do harm to vulnerable participantsNearly 80% of participants in FDA-reviewed research trials live in foreign countries.Bet_Noire/iStock via Getty Images

The Research Brief is a short take about interesting academic work.

The Big Idea

The Food and Drug Administration provides less stringent oversight of overseas research trials used in deciding whether to approve a drug than those...

Read more: The FDA's lax oversight of research in developing countries can do harm to vulnerable participants

More Articles ...

  1. Transgender and gender diverse teens: How to talk to and support them
  2. Hip-hop's love-hate relationship with education
  3. Chief Keef changed the music industry – and it's time he gets the credit he deserves
  4. How 2 Jewish soldiers' court-martials put a spotlight on antisemitism and racism
  5. Nurses don't want to be hailed as 'heroes' during a pandemic – they want more resources and support
  6. Why building more homes won't solve the affordable housing problem for the millions of people who need it most
  7. The Hatch Act, the law Trump deputies are said to have broken, requires government employees to work for the public interest, not partisan campaigns
  8. ¿Qué es el metaverso, futuro de la convivencia humana?
  9. Why are prices so high? Blame the supply chain – and that's the reason inflation is here to stay
  10. Genetic GPS system of animal development explains why limbs grow from torsos and not heads
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more